NasdaqGS - Nasdaq Real Time Price USD
Krystal Biotech, Inc. (KRYS)
167.70
-1.10
(-0.65%)
As of 1:34:09 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 167,500 | 3 |
| Sales | 200,750 | 5 |
| Net Shares Purchased (Sold) | -33,250 | 8 |
| Total Insider Shares Held | 3.52M | -- |
| % Net Shares Purchased (Sold) | -0.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | Sale at price 175.83 - 179.57 per share. | Indirect | 8,889,525 | Mar 13, 2025 |
| KRISHNAN KRISH S Chief Executive Officer | Sale at price 175.83 - 179.57 per share. | Indirect | 8,889,525 | Mar 13, 2025 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | -- | Indirect | -- | Feb 28, 2025 |
| KRISHNAN KRISH S Chief Executive Officer | -- | Indirect | -- | Feb 28, 2025 |
| ROMANO KATHRYN Officer | -- | Direct | -- | Feb 28, 2025 |
| ROMANO KATHRYN Officer | Sale at price 175.22 per share. | Direct | 131,415 | Feb 27, 2025 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | Sale at price 163.04 - 171.63 per share. | Indirect | 8,240,023 | Dec 13, 2024 |
| KRISHNAN KRISH S Chief Executive Officer | Sale at price 163.04 - 171.63 per share. | Indirect | 8,240,023 | Dec 13, 2024 |
| ROSSI DINO A Director | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 13, 2024 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | Sale at price 195.16 - 201.81 per share. | Indirect | 9,888,276 | Sep 12, 2024 |
| KRISHNAN KRISH S Chief Executive Officer | Sale at price 195.16 - 201.81 per share. | Indirect | 9,888,276 | Sep 12, 2024 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | Sale at price 171.40 - 178.36 per share. | Indirect | 8,788,062 | Jun 11, 2024 |
| KRISHNAN KRISH S Chief Executive Officer | Sale at price 171.40 - 178.36 per share. | Indirect | 8,788,062 | Jun 11, 2024 |
| GANGOLLI JULIAN S Director | Sale at price 163.71 - 165.76 per share. | Direct | 3,282,690 | May 20, 2024 |
| GANGOLLI JULIAN S Director | Conversion of Exercise of derivative security at price 22.75 per share. | Direct | 455,000 | May 20, 2024 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | Sale at price 167.99 - 174.13 per share. | Indirect | 8,547,719 | Mar 11, 2024 |
| KRISHNAN KRISH S Chief Executive Officer | Sale at price 167.99 - 174.13 per share. | Indirect | 8,547,719 | Mar 11, 2024 |
| ROMANO KATHRYN Officer | Sale at price 162.73 - 171.66 per share. | Direct | 1,195,026 | Feb 28, 2024 |
| ROMANO KATHRYN Officer | Sale at price 162.71 - 172.23 per share. | Direct | 829,417 | Feb 28, 2024 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | -- | Indirect | -- | Feb 28, 2024 |
| KRISHNAN KRISH S Chief Executive Officer | -- | Indirect | -- | Feb 28, 2024 |
| ROMANO KATHRYN Officer | Conversion of Exercise of derivative security at price 63.55 per share. | Direct | 457,560 | Feb 28, 2024 |
| ROMANO KATHRYN Officer | Conversion of Exercise of derivative security at price 63.55 per share. | Direct | 317,750 | Feb 28, 2024 |
| ROMANO KATHRYN Officer | Conversion of Exercise of derivative security at price 52.26 per share. | Direct | 522,600 | Feb 27, 2024 |
| ROMANO KATHRYN Officer | Sale at price 135.00 - 140.00 per share. | Direct | 1,107,180 | Feb 26, 2024 |
| ROMANO KATHRYN Officer | Sale at price 130.00 per share. | Direct | 325,000 | Jan 22, 2024 |
| ROMANO KATHRYN Officer | Conversion of Exercise of derivative security at price 52.26 per share. | Direct | 130,650 | Jan 22, 2024 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | Sale at price 104.26 - 107.66 per share. | Indirect | 5,283,291 | Dec 11, 2023 |
| KRISHNAN KRISH S Chief Executive Officer | Sale at price 104.26 - 107.66 per share. | Indirect | 5,283,291 | Dec 11, 2023 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | Sale at price 125.23 - 129.10 per share. | Indirect | 6,361,680 | Sep 11, 2023 |
| KRISHNAN KRISH S Chief Executive Officer | Sale at price 125.23 - 129.10 per share. | Indirect | 6,361,680 | Sep 11, 2023 |
| JANNEY DANIEL SPENCER Director | Sale at price 127.86 - 129.29 per share. | Indirect | 6,418,077 | Jun 9, 2023 |
| ORTH ANDREW C Officer | Sale at price 128.10 - 129.70 per share. | Direct | 1,607,635 | Jun 9, 2023 |
| ORTH ANDREW C Officer | Conversion of Exercise of derivative security at price 63.55 per share. | Direct | 794,375 | Jun 9, 2023 |
| KRISHNAN SUMA M Officer, Director and Beneficial Owner | Sale at price 115.98 - 117.60 per share. | Indirect | 5,809,889 | May 31, 2023 |
| KRISHNAN KRISH S Chief Executive Officer | Sale at price 115.98 - 117.60 per share. | Indirect | 5,809,889 | May 31, 2023 |
| ROMANO KATHRYN Officer | Sale at price 95.04 - 110.00 per share. | Direct | 5,428,115 | May 22, 2023 |
| ROMANO KATHRYN Officer | Conversion of Exercise of derivative security at price 52.26 - 63.55 per share. | Direct | 2,754,125 | May 22, 2023 |
| JANNEY DANIEL SPENCER Director | Sale at price 95.02 per share. | Indirect | 4,751,185 | May 19, 2023 |
| JANNEY DANIEL SPENCER Director | Sale at price 90.74 per share. | Indirect | 1,551,579 | May 9, 2023 |
Related Tickers
ASND Ascendis Pharma A/S
156.66
-1.56%
NUVL Nuvalent, Inc.
73.78
+3.35%
BPMC Blueprint Medicines Corporation
85.33
+2.30%
PTCT PTC Therapeutics, Inc.
49.48
+2.68%
KYMR Kymera Therapeutics, Inc.
30.22
+4.93%
CGEM Cullinan Therapeutics, Inc.
8.48
+1.31%
RYTM Rhythm Pharmaceuticals, Inc.
60.84
+2.72%
RARE Ultragenyx Pharmaceutical Inc.
37.40
+4.15%
MGTX MeiraGTx Holdings plc
6.44
+2.71%
ALNY Alnylam Pharmaceuticals, Inc.
240.58
+1.62%